Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
Beteiligte:
van Egmond, Noëlle;
Straub, Verena M.;
van der Stelt, Mario
Erschienen:
Annual Reviews, 2021
Erschienen in:Annual Review of Pharmacology and Toxicology
Sprache:
Englisch
DOI:
10.1146/annurev-pharmtox-030220-112741
ISSN:
0362-1642;
1545-4304
Entstehung:
Anmerkungen:
Beschreibung:
<jats:p> Inspired by the medicinal properties of the plant Cannabis sativa and its principal component (−)- trans-Δ<jats:sup>9</jats:sup>-tetrahydrocannabinol (THC), researchers have developed a variety of compounds to modulate the endocannabinoid system in the human brain. Inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL), which are the enzymes responsible for the inactivation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol, respectively, may exert therapeutic effects without inducing the adverse side effects associated with direct cannabinoid CB<jats:sub>1</jats:sub> receptor stimulation by THC. Here we review the FAAH and MAGL inhibitors that have reached clinical trials, discuss potential caveats, and provide an outlook on where the field is headed. </jats:p>